Immune microenvironment profiling of breast cancer brain metastases using multiplex immunofluorescence. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not ...
Although clinical improvement is almost universal with therapy in patients with POEMS (an acronym for polyneuropathy, organomegaly, endocrinopathies, monoclonal protein and a variety of skin changes) ...
Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with HER2-positive metastatic breast cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback